Strategic leader with 12 years of experience driving Medical Affairs, Commercial, and Access strategy across biotech and pharmaceutical organizations. I specialize in translating scientific and market insights into enterprise-wide impact—supporting launch readiness, evidence generation, and cross-functional portfolio execution in complex, global environments.
Execution-Oriented Strategy:
I bring an operations mindset to strategy, aligning enterprise priorities with actionable plans across Medical Affairs, Commercial, Market Access, HEOR, and Regulatory functions. My consulting background and agency experience have enabled partnerships with senior leaders to deliver scalable frameworks that accelerate value from development through commercialization.
Therapeutic & Functional Breadth:
Hands-on leadership across oncology, hematology, immunology, rare disease, HIV, neurology, and more—spanning evidence strategy, market shaping, payer engagement, omnichannel campaigns, and stakeholder alignment.
Track Record of Impact:
At Syneos and Harrison & Star, I’ve led strategic initiatives that enabled global launch success, strengthened Medical/Commercial integration, improved cross-functional execution, and supported over $6M in high-priority initiatives.
From building value messaging platforms to managing portfolio strategy transformation, I focus on driving measurable outcomes. I’m passionate about enabling meaningful progress in biopharma by bridging insights, innovation, and execution. If you’re building the future of healthcare strategy—let’s connect.
